Intervertebral Disc Herniation: Diagnosis, Conservative Care, and Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Intervertebral disc herniation occurs when the nucleus pulposus — the gelatinous core of an intervertebral disc — breaches the annulus fibrosus and impinges on adjacent neural structures. The condition is classified by morphology: protrusion (disc material extends beyond the disc margin but annular fibres remain intact), extrusion (nucleus pulposus escapes through a full-thickness annular tear), and sequestration (a free disc fragment migrates within the spinal canal). A contained herniation retains a thin outer annular layer; a non-contained herniation does not.

Disc herniation most commonly affects the lumbar spine at L4/5 and L5/S1, accounting for approximately 90% of lumbar cases. In the cervical spine, C5/6 and C6/7 are most frequently involved. Thoracic disc herniation is rare (<1% of cases) but can present with myelopathy when it occurs centrally.

MRI is the investigation of choice and is graded using the Pfirrmann classification (Grades I–V): Grade I represents a healthy, bright disc on T2 sequences; Grade V is a completely collapsed, hypointense disc with no height. This grading correlates with symptom severity and guides prognosis. CT myelography is reserved for patients unable to undergo MRI or when MRI findings are equivocal.

The natural history of disc herniation is generally favourable. Landmark data confirm that 70–80% of patients improve significantly without surgery within 12 weeks through a combination of resorption of the herniated fragment, reduction in inflammatory mediators, and neural accommodation. This biological resorption is most complete in large extrusions and sequestrations, which paradoxically carry a better spontaneous recovery rate than small protrusions.

Patient-reported outcomes, functional status, and the presence of red-flag features guide the decision to escalate from conservative to interventional or surgical management. Shared decision-making, grounded in realistic expectation-setting, is central to modern disc herniation care.

The clinical syndrome produced by disc herniation depends on the spinal level and the direction of herniation — posterolateral herniation compresses the traversing or exiting nerve root, whereas central herniation endangers the spinal cord (in the cervical and thoracic spine) or the cauda equina (lumbar).

Lumbar disc herniation classically presents as sciatica: unilateral radiating leg pain following a dermatomal distribution, often worse with sitting, coughing, or Valsalva manoeuvre. An L4/5 herniation compresses the L5 root, causing weakness of ankle dorsiflexion and extensor hallucis longus (foot drop), and sensory loss over the dorsum of the foot. An L5/S1 herniation compresses the S1 root, producing diminished ankle reflex, plantar flexion weakness, and posterolateral calf sensory deficit. The straight leg raise (SLR) test is positive at <60° with radicular reproduction and has high sensitivity (72–97%) for lumbar disc herniation. The crossed SLR increases specificity to over 90% and suggests a large or central herniation.

Cervical disc herniation causes cervical radiculopathy: neck pain radiating into the arm with paraesthesia, weakness, and reflex changes in the affected myotome and dermatome. The Spurling test (axial compression with ipsilateral rotation and lateral bending) reproduces radicular symptoms and has high specificity (>90%). C6 radiculopathy causes biceps reflex loss and thumb/index finger paraesthesia; C7 radiculopathy causes triceps reflex loss and middle finger numbness. Large central cervical disc herniations cause cervical myelopathy — progressive hand clumsiness, spastic gait, Lhermitte phenomenon, and upper motor neuron signs (hyperreflexia, Babinski, Hoffmann sign).

Cauda equina syndrome from massive central lumbar herniation is a surgical emergency requiring same-day decompression, characterised by bilateral leg weakness, saddle anaesthesia, and bladder/bowel dysfunction.

The majority of patients with disc herniation are suitable for initial conservative management. Surgical consultation is appropriate when symptoms persist beyond 6–12 weeks of structured conservative therapy, when functional limitation is severe, or when clinical or imaging red flags are present.

Candidates for conservative management include patients with a single-level herniation, radicular symptoms without significant motor deficit, and no myelopathic signs. Imaging showing concordant pathology (herniation matching the clinical level) increases confidence in non-surgical management.

Relative surgical indications: persistent or worsening radiculopathy despite 6 weeks of conservative care; motor weakness of MRC Grade 3 or below; failure of transforaminal epidural steroid injection; significant functional disability affecting work or daily activities.

Absolute surgical indications — immediate referral required: cauda equina syndrome (bladder/bowel dysfunction, saddle anaesthesia); progressive motor deficit (foot drop worsening over days); cervical myelopathy with functional decline; thoracic disc herniation with myelopathic signs.

Pre-operative assessment includes MRI correlation with clinical findings, assessment of bone quality (particularly important for cervical fusion), nutritional and diabetic status (smoking, obesity, and uncontrolled diabetes increase revision risk), and psychological screening. The Keele STarT Back Screening Tool and the Örebro Musculoskeletal Pain Questionnaire identify psychosocial risk factors for poor outcomes and guide pre-operative rehabilitation planning. Patients with high psychosocial risk scores benefit from multidisciplinary pain management input before surgery.

Conservative (First-Line) Management: NSAIDs (naproxen, diclofenac) are the pharmacological mainstay and reduce inflammatory prostaglandins at the disc–nerve interface. Short courses of oral corticosteroids provide moderate short-term relief but do not alter long-term outcomes. Physiotherapy emphasises nerve mobilisation, McKenzie directional preference exercises for lumbar herniation, and deep cervical flexor strengthening for cervical herniation. Structured activity modification — avoiding positions that increase intradiscal pressure — is combined with graded return to daily activities.

Transforaminal Epidural Steroid Injection (TESI): A landmark comparative effectiveness trial (NEJM 2014, Friedly et al.) demonstrated that lumbar TESI with corticosteroid provided greater short-term pain relief than lidocaine alone at 6 weeks but similar outcomes at 3 months. Image-guided TESI delivers methylprednisolone or triamcinolone to the periradicular space, reducing local inflammation and oedema. Up to two injections per episode are appropriate; three or more in six months increase systemic corticosteroid exposure without proportionate benefit. Cervical TESI carries higher risk than lumbar and requires meticulous image guidance to avoid vertebral artery injection or inadvertent intrathecal placement.

Lumbar Microdiscectomy: The SPORT (Spine Patient Outcomes Research Trial) — the largest RCT in spinal surgery — demonstrated that surgery was superior to non-operative care at 2-year follow-up for sciatica-dominant lumbar disc herniation: greater reduction in the Oswestry Disability Index, leg pain VAS, and SF-36 bodily pain scores. As-treated analysis consistently favoured surgery; intention-to-treat analysis was attenuated by high crossover rates. Microdiscectomy uses a small posterior incision, microscopic magnification, and limited bone resection (hemi-laminotomy or fenestration) to remove the herniated fragment while preserving the annulus and facet joints.

Endoscopic Disc Surgery (PELD/TESSYS): Percutaneous endoscopic lumbar discectomy (PELD) — including the transforaminal (PELD-TF) and interlaminar (PELD-IL) approaches — and the TESSYS system achieve equivalent clinical outcomes to microdiscectomy with smaller incisions, less muscle damage, lower blood loss, and faster return to work. Multiple systematic reviews (2020–2024) confirm non-inferiority; adoption is limited by steep learning curve and equipment cost.

Cervical Disc Surgery: Anterior cervical discectomy and fusion (ACDF) is the gold standard for cervical radiculopathy: anterior exposure, complete discectomy, foraminotomy, and interbody fusion with cage and plate. The PRESTIGE trial compared ACDF against cervical disc arthroplasty (CDA) at 7-year follow-up and demonstrated non-inferiority of CDA for neural outcomes with superior motion preservation and lower adjacent-segment disease rates — making CDA the preferred option in younger, active patients at appropriate levels. Posterior foraminotomy is a motion-preserving alternative for posterolateral soft disc herniation without instability.

Effective treatment of disc herniation — whether conservative or surgical — restores neurological function, eliminates disabling pain, and allows return to normal activity. The following benefits are supported by high-quality evidence:

Conservative management avoids operative risk entirely and achieves complete or near-complete resolution in the majority of patients within 12 weeks. Structured physiotherapy improves functional outcomes and reduces recurrence risk. Transforaminal steroid injection can provide sufficient pain relief to bridge patients through the natural history period and enable active physiotherapy participation.

Microdiscectomy and endoscopic discectomy produce faster and more complete relief of leg pain (sciatica) than continued conservative care, as demonstrated in the SPORT trial. Most patients experience immediate radicular pain relief on recovery from anaesthesia as neural decompression is achieved. Return to driving is typically at 2–4 weeks; return to sedentary work at 2–6 weeks; return to manual work at 6–12 weeks. The procedure is associated with short inpatient stay (often day-case or overnight) and low perioperative complication rates.

ACDF reliably decompresses cervical nerve roots, provides biomechanical stability, and prevents recurrent herniation at the operated level. High fusion rates (95%+) are achieved with modern cage designs. Neurological recovery — particularly motor weakness from radiculopathy — is excellent when decompression is achieved within weeks to months of symptom onset. Cervical disc arthroplasty additionally preserves segmental motion, reducing the theoretical long-term risk of adjacent-segment degeneration.

For patients with cervical myelopathy, early surgical decompression halts progression and often produces partial or complete neurological recovery — delayed surgery beyond 12–18 months of myelopathic symptoms is associated with inferior functional recovery.

All interventions for disc herniation carry specific risks that must be balanced against expected benefit during informed consent.

Conservative and injection risks: Prolonged conservative management delays recovery in patients who would ultimately benefit from surgery. Epidural steroid injections carry rare but serious risks including epidural haematoma, infection (discitis, epidural abscess), and — for cervical injections — vertebral artery injury with catastrophic stroke. Repeated injection increases hypothalamic–pituitary–adrenal axis suppression and local tissue atrophy.

Microdiscectomy risks: Overall complication rate is 1–4% in experienced hands. Specific risks include: dural tear with CSF leak (2–3% — managed with primary repair or blood patch); nerve root injury (<1% — risk increased by severe canal stenosis, revision surgery, or anomalous anatomy); discitis (0.5–1% — requires prolonged antibiotic therapy); wound haematoma; incomplete decompression with residual symptoms; and disc reherniation at the same level (5–15% at 10 years — highest in first year post-operatively, risk factors include obesity, heavy lifting, and early return to strenuous activity).

ACDF-specific risks: Dysphagia and hoarseness (10–15% early, resolving in most); recurrent laryngeal nerve palsy (<1%); adjacent-segment disease (2–3% per year — accelerated degeneration at levels above and below fusion, cumulative risk ~25% at 10 years, motivating motion-preserving alternatives); pseudarthrosis (non-union, ~3–5%); and hardware failure or migration.

Cervical disc arthroplasty risks: Implant heterotopic ossification (occurring in up to 20% at 5+ years, negating motion benefit); device migration; and the theoretical (unproven) risk of implant wear-debris reaction over decades.

Red flags warranting emergency assessment: New or worsening bladder/bowel dysfunction, rapidly progressive bilateral leg weakness, or saddle anaesthesia represent cauda equina syndrome — a neurosurgical emergency.

Structured follow-up after disc herniation treatment — whether conservative or surgical — is essential to monitor neurological recovery, ensure safe return to activity, and detect complications or recurrence.

After conservative management: Review at 6 weeks to assess progress. Patients failing to improve by 12 weeks warrant specialist referral and repeat MRI if imaging has not been performed. Physiotherapy continues until full functional recovery; core stability and lumbar endurance exercise programmes reduce the risk of recurrence and should be maintained long-term.

After microdiscectomy or endoscopic discectomy: Wound review at 10–14 days. Physiotherapy commences at 2–4 weeks post-operatively, focusing initially on walking, then progressive lumbar stabilisation, and finally functional strengthening. MRI is not routinely repeated unless symptoms recur or worsen — post-operative imaging in the first 6–12 weeks shows residual epidural fibrosis and disc material that can be misinterpreted as reherniation. Neurological deficits (motor weakness, sensory change) are reassessed at 6 weeks; recovery is expected within 3–6 months, though pre-existing longstanding deficits may be permanent.

After ACDF or CDA: Radiographs at 6 weeks, 3 months, and 12 months assess fusion progression (ACDF) or implant position (CDA). A soft cervical collar is used for comfort only (not immobilisation) for 2–4 weeks. Physiotherapy includes cervical range-of-motion exercises, deep flexor strengthening, and postural correction. Return to office work typically at 4–6 weeks; return to manual work at 10–12 weeks post-ACDF.

Persistent radicular symptoms beyond 3–6 months post-surgery should prompt MRI to exclude reherniation, residual compression, or adjacent-segment pathology. Multidisciplinary pain management is indicated for patients with central sensitisation phenotypes who fail to respond to decompressive surgery.

The cost of disc herniation treatment varies substantially by country, treatment modality, and healthcare setting. Understanding cost drivers helps patients plan appropriately and evaluate medical tourism options.

Key cost factors: Treatment modality (conservative physiotherapy being lowest cost; endoscopic surgery intermediate; ACDF/CDA being highest); hospital type (private vs. public); implant choice (titanium interbody cages with anterior plates vs. PEEK cages; motion-preserving artificial disc devices command a significant implant premium); surgeon experience and subspecialty fellowship training; anaesthesia type; and length of inpatient stay.

Country-level cost comparison (approximate, USD):

• United States: Microdiscectomy USD 20,000–40,000; ACDF USD 30,000–65,000; cervical disc arthroplasty USD 40,000–80,000
• United Kingdom (private): Microdiscectomy GBP 8,000–18,000; ACDF GBP 12,000–22,000
• India: Microdiscectomy USD 3,000–6,000; ACDF/CDA USD 5,000–10,000 — savings of 75–85% vs. US prices at JCI-accredited centres
• Thailand: Microdiscectomy USD 6,000–12,000; ACDF USD 8,000–15,000
• Turkey: Microdiscectomy USD 4,000–8,000; ACDF USD 6,000–12,000

Pre-operative consultation, MRI review, physiotherapy courses, and post-operative follow-up appointments are additional expenses that patients should budget for, particularly when travelling internationally. Repatriation insurance is strongly recommended for patients undergoing spinal surgery abroad.

Many patients with disc herniation achieve satisfactory outcomes without surgery, and several non-operative modalities are supported by clinical evidence.

Structured physiotherapy: The most important non-surgical intervention. McKenzie method (directional preference exercises) is effective for lumbar disc herniation and can centralise peripheralised pain within sessions. Neural mobilisation techniques (sciatic nerve gliding) reduce radicular sensitivity. Cervical traction — either manual or mechanical — reduces foraminal narrowing and may provide short-term relief for cervical radiculopathy.

Pharmacological alternatives: Pregabalin and gabapentin reduce neuropathic radicular pain; duloxetine is an evidence-based alternative. Muscle relaxants (cyclobenzaprine, methocarbamol) address secondary paravertebral spasm. Opioids should be avoided or minimised for disc herniation; they do not alter the underlying pathology and carry significant dependency risk in a predominantly working-age population.

Transforaminal epidural steroid injection (TESI): As described above — an effective bridge therapy and a reasonable alternative to early surgery in patients willing to wait for natural history resolution. Repeat injection at 4–6 weeks if initial response is partial.

Radiofrequency ablation / pulsed radiofrequency: Pulsed radiofrequency of the dorsal root ganglion (DRG-PRF) has emerging evidence for refractory radicular pain without motor deficit, offering non-destructive neuromodulation. Traditional continuous radiofrequency of the DRG is generally avoided due to risk of deafferentation pain.

Intradiscal procedures: Ozone nucleolysis, plasma disc decompression, and intradiscal electrothermal therapy (IDET) have been investigated as alternatives to discectomy; evidence for efficacy is inconsistent and none are recommended as standard care by major spinal societies. They should be considered only within research settings or for carefully selected patients who decline surgery.